3 June, 2017 by The TZ Newswire Staff Comments Off on 2017’s Best Performing DJIA Stock: Apple
2017’s Best Performing DJIA Stock: Apple
Apple continues its streak as the best performing stock among the 30 stocks comprising the Dow Jones Industrial Average. The company’s developer conference begins Monday.
3 June, 2017 by The TZ Newswire Staff Comments Off on 3 Reasons Why Disney World Attendance Will Bounce Back in 2017
3 Reasons Why Disney World Attendance Will Bounce Back in 2017
Disney (NYSE: DIS) had a rough year wooing theme-park visitors last year. The media giant doesn’t typically offer up annual theme-park numbers, but industry tracker Themed Entertainment Association has been offering up its estimates for years — and on Thursday, it put out some bleak numbers for the House of Mouse.
3 June, 2017 by The TZ Newswire Staff Comments Off on Proof of Blockchain Protocols Coming of Age: Sasha Ivanov, CEO of Wave, Speaks at SPIEF
Proof of Blockchain Protocols Coming of Age: Sasha Ivanov, CEO of Wave, Speaks at SPIEF
Not only was Megan Kelly grilling Vladimir Putin at the St. Petersburg International Economic Forum (SPIEF) this week but other hot topics surround Fintech were on the schedule. One of these topics was the “Explosive Impact of Blockchain Technology” which included the participation of Waves… Read More
3 June, 2017 by The TZ Newswire Staff Comments Off on Competing — and Winning — Against Multiple Bids for the Home You Want
Competing — and Winning — Against Multiple Bids for the Home You Want
Tight housing inventory and higher prices are a given in today’s home buying market. Be prepared to compete with multiple bids for the house you want, and keep these tricks in mind if you want the…
3 June, 2017 by The TZ Newswire Staff Comments Off on What Analysts Have to Say About Walgreens Ahead of the Merger Deadline
What Analysts Have to Say About Walgreens Ahead of the Merger Deadline
Analysts have taken the perspective that the Walgreens/Rite Aid deal might be too difficult to call correctly, and those covering it generally have created two scenarios about what could happen.
3 June, 2017 by The TZ Newswire Staff Comments Off on 3 Stocks With Vertex Pharmaceuticals-Like Return Potential
3 Stocks With Vertex Pharmaceuticals-Like Return Potential
Over the past decade, Vertex Pharmaceuticals (NASDAQ: VRTX) stock has tripled in value, thanks in large part to the success of its core cystic fibrosis drug franchise. With this biotech’s shares now trading at a sky-high forward price-to-earnings ratio of 41, however, it might be the perfect time to look elsewhere for more attractive growth opportunities.
3 June, 2017 by The TZ Newswire Staff Comments Off on 4 Major Stocks That Analysts Want You to Buy Now
4 Major Stocks That Analysts Want You to Buy Now
Four analyst calls stood out from the rest of those calls during the week of June 2, 2017. Some are in blue chip stocks and others in companies that are becoming large enough they could be blue chips.